Combine chemoradiation therapy with DAPK1 gene target |
DAPK1 |
Suppress the proliferation of tumor cells and induce apoptosis and autophagy |
Advantages: Decrease side effects Disadvantages: Not mentioned |
Bhattacharjee et al., 2018; Huang et al., 2018; Ren et al., 2018; Sood et al., 2018; Wang et al., 2018; Yadav et al., 2018
|
Combine chemoradiation therapy with BRCA1 gene target |
BRCA1 |
DNA damage repair, transcriptional regulation and apoptosis |
Advantages: Decrease side effects Disadvantages: The overexpression of BRCA1 gene may improve tumorigenesis |
Li et al., 2018a; Maresca et al., 2018; Sood et al., 2018; Sun et al., 2018
|
Combine chemoradiation therapy with MGMT gene target |
MGMT |
Repair cytotoxic lesions by removing the methyl adducts from DNA |
Advantages: Decrease side effects Disadvantages: Not mentioned |
Jiapaer et al., 2018; Ren et al., 2018; Scicchitano et al., 2018; Sood et al., 2018; Yuan et al., 2018
|
Menthol |
FANCF |
Reverse the hypermethylation of FANCF promoter |
Advantages: Menthol has high solubility and bioavailability Disadvantages: Not mentioned |
Parashar et al., 2017 |
EGCG with eugenol-amarogentin |
LimD1 and P16
|
Suppress proliferation and induce apoptosis through promoting the hypomethylation of LimD1 and P16 promoters |
Advantages: More effective Disadvantages: Not mentioned |
Pal et al., 2018 |
Combine chemoradiation therapy with STK31 gene target |
STK31 |
Suppress migration and invasiveness and induce apoptosis |
Advantages: Increase the efficacy of chemoradiation and reduce chemoresistance Disadvantages: Epigenetics drugs have many restrictions |
Yin et al., 2016 |
Quercetin |
TSG |
Downregulate the levels of global DNA methylation and reverse the hypermethylation of TSG promoter |
Advantages: Natural and fewer side effects Disadvantages: Low bioavailability |
Kedhari Sundaram et al., 2019 |
Limoniastrum guyonianum aqueous gall extract (G extract) and luteolin |
p16INK4A |
Suppress the proliferation and induce apoptosis by activating p16INK4A-dependent cell cycle checkpoint signaling pathway |
Advantages: Natural and fewer side effects Disadvantages: Not experiment in vivo and have no idea if it works for patients |
Krifa et al., 2013 |